Manhattan Scientifics Inc financial data

Symbol
MHTX on OTC
Industry
Miscellaneous Electrical Machinery, Equipment & Supplies
Location
244 Fifth Avenue, Suite 2341, New York, New York
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
Q1 2024 - May 15, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 3.4 % -77.7%
Debt-to-equity -74.5 % +28.1%
Return On Equity 40.8 % -74.2%
Return On Assets -320 % -42.4%
Operating Margin -7.93K % -379%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 559M shares 0%
Common Stock, Shares, Outstanding 559M shares 0%
Entity Public Float 2.6M USD -45%
Common Stock, Value, Issued 559K USD 0%
Weighted Average Number of Shares Outstanding, Basic 559M shares 0%
Weighted Average Number of Shares Outstanding, Diluted 559M shares 0%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 0 USD -100%
Research and Development Expense 13K USD +62.5%
General and Administrative Expense 696K USD -3.87%
Operating Income (Loss) -709K USD -3.96%
Nonoperating Income (Expense) -2.05M USD +30.5%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -1.13M USD +55%
Earnings Per Share, Basic 0 USD/shares
Earnings Per Share, Diluted 0 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 52K USD -86.5%
Assets, Current 60K USD -47.8%
Property, Plant and Equipment, Net 0 USD -100%
Assets 91K USD -86.9%
Accrued Liabilities, Current 2.05M USD +33.2%
Liabilities, Current 2.28M USD +29.9%
Liabilities 2.28M USD +29.9%
Convertible Preferred Stock, Nonredeemable or Redeemable, Issuer Option, Value 1.06M USD 0%
Retained Earnings (Accumulated Deficit) -72.8M USD -1.57%
Stockholders' Equity Attributable to Parent -3.24M USD -53.3%
Liabilities and Equity 91K USD -86.9%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -42K USD +44%
Net Cash Provided by (Used in) Financing Activities 0 USD
Net Cash Provided by (Used in) Investing Activities 26K USD
Common Stock, Shares Authorized 950M shares 0%
Common Stock, Shares, Issued 559M shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -57K USD +52.9%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 51K USD -43.3%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Operating Loss Carryforwards 13.7M USD +1.81%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 1M shares 0%
Additional Paid in Capital 69M USD 0%
Preferred Stock, Shares Outstanding 0 shares
Interest Expense 0 USD -100%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%